Week Ahead – Let the debates begin!
Novavax teases Covid-19 vaccine trial design as it kicks off UK study — US to follow next month
Africa Is The Undeniable Final Frontier For Oil
US-Africa trade relations: Why is AGOA better than a bilateral free trade agreement?
Norwegian university supplying COVID-19 test kits to India, Denmark
FDX and UPS Could Be Winners In Solving COVID-19 Vaccine Distribution Challenges
Where in the world will the next epidemic start?
Commodity currencies crash on USD dominance
Fine Wine Market: US & Emerging Market Report
J&J’s One-Dose COVID-19 Vaccine Candidate Begins Phase III Trial
Futures Extend Rebound As Nike Soars, Tesla Tumbles; Powell On Deck For 2nd Day
Nike Pops 13% As 1Q Online Sales Jump 82%
3 "Strong Buy" Gold Stocks to Hedge Volatility
The world is designed for men – but smart energy systems don't have to be
Global Stocks Plunge On Bank, Election, Virus Fears; Treasuries, Dollar Spike
China Is Killing The Dollar
Week Ahead – No ease up for Powell
Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial
How the modern world was shaped by epidemics 500 years ago
International study will compare different countries’ responses to COVID-19
Futures Slide After Fed "Not-Dovish-Enough", Tech Tumbles On Reflation Rotation Fears
Covid-19 roundup: Trump questions Redfield after hearing remarks; Oxford suggests side effect not caused by vaccine
Illumina Eyes Grail Acquisition For Over $8B – Report
AstraZeneca’s trial illnesses may not be due to Covid-19 shot, Oxford University says
AstraZeneca’s trial illnesses may not be due to Covid-19 shot – Oxford University
Chart of the WeekTrade as a Tool for an Efficient Recovery
AstraZeneca resumes UK trials of Covid-19 vaccine halted by patient illness
Unpopular but essential – petroleum products improve lives in unappreciated ways
Inflation, Deflation, & Other Fallacies
Week ahead – More stimulus on the way?